Thymalin: Research Overview and Mechanism

Thymalin is a thymus-derived polypeptide fraction rather than a single defined molecule. As a heterogeneous extract it has no single molecular formula, molecular weight, or sequence, and its composition is characterized on the lot Certificate of Analysis rather than expressed as one value. It belongs to the class of thymic peptide preparations studied in Russian immunology and gerontology research as peptide bioregulators, and it should not be conflated with the defined synthetic nonapeptide Thymulin, which the market sometimes confuses with it.

In research, Thymalin is studied within immune-signaling and thymic-peptide models as a representative thymus polypeptide fraction, where it is examined for association with T-cell and immune-cell modulation. Because it is a mixture rather than one molecule, peptide-extract characterization research treats the heterogeneity of the fraction itself as a subject of study, contrasting an extract with a defined single-peptide reference such as Thymosin Alpha-1.

These descriptions refer to thymic-extract research applications, not to human outcomes, and the material here is for laboratory research only and is not approved for human use.

Pinnacle Thymalin ships as a 10mg lyophilized powder, and because it is a thymus-derived polypeptide fraction rather than a single molecule it carries no one formula or molecular weight; its composition and purity characteristics are documented on the lot-matched Certificate of Analysis rather than as a single value (the fraction is often catalogued under CAS 79621-14-0, which should be reconciled against that document). Store the sealed vial at -20°C protected from light and reconstitute with bacteriostatic water for research use, confirming that the paperwork describes Thymalin and not the unrelated nonapeptide Thymulin.